Chain Drug Review - Aldara approved
April 26, 2004 -- 3M Pharmaceuticals has obtained regulatory approval for the first immune response modifier to treat actinic keratosis. The patient-applied Aldara...
Journal of Drugs in Dermatology - Intron-A/Aldara combination therapy for BCC
February 1, 2008 -- Sponsored by: The University of Texas Health Science Center, Houston. The purpose of this study is to see if BCC excluding the scalp and face can be...
Dermatology Nursing - Patients with actinic keratosis may benefit from Aldara™ Cream
June 1, 2006 -- According to a study published in a 2005 issue of Dermatologic Surgery, prescription Aldara[TM] (imiquimod) Cream 5%, delivers long-term clinical...
Business Wire - Graceway Pharmaceuticals Reports Study in New England Journal of Medicine: ALDARA® Cream, 5% demonstrated a reduction in lesion size in patients with...
April 21, 2008 -- BRISTOL, Tenn. -- A study published in the April 3, 2008 issue of The New England Journal of Medicine concludes that imiquimod cream, 5% (Aldara)...
Business Wire - Graceway Pharmaceuticals Reports Study in British Journal of Dermatology: Patients Treated with ALDARA Experienced Higher Levels of Histological and Sustained...
April 16, 2008 -- BRISTOL, Tenn. -- Graceway Pharmaceuticals, LLC today announced the results from a study comparing 3 different treatments for actinic keratosis, a...
Internal Medicine News - Aldara for genital warts
June 1, 2002 -- Aldara (imiquimod) cream 5%, a topical therapy for external genital warts, is now indicated for patients aged 12 years and older. Previously, Aldara...
Dermatology Nursing - Aldara™ receives FDA approval for treating actinic keratosis
June 1, 2005 -- 3M announced the U.S. Food and Drug Administration was granted marketing approval for Aldara (imiquimod) Cream, 5%, a topical prescription treatment...
Business Wire - Aldara Cream, 5% Included in Multiple Poster Presentations at American Academy of Dermatology's ACADEMY 06 Meeting
July 27, 2006 -- ST. PAUL, Minn. -- Aldara is First and Only Immune Response Modifier Indicated for the Treatment of Actinic Keratosis, Superficial Basal Cell...
Skin & Allergy News - Long-term use of Aldara safe in AK patients
April 1, 2005 -- NEw ORLEANS -- There is a low incidence of new actinic keratoses after topical imiquimod 5% cream treatment, according to data from a long-term...
Business Wire - Aldara™ Cream, 5% Included in More Than 20 Presentations at American Academy of Dermatology's 64th Annual Meeting
March 2, 2006 -- ST. PAUL, Minn. -- 3M (NYSE:MMM): --Aldara is the First and Only Immune Response Modifier Indicated for the Treatment of Actinic Keratosis,...
